Gilead Sciences Stock Price History
| GILD Stock | USD 66.93 0.38 0.56% |
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 66.93, as last reported on the 19th of April, with the highest price reaching 67.54 and the lowest price hitting 66.89 during the day.
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. Gilead Sciences holds Efficiency (Sharpe) Ratio of -0.22, which attests that the entity had a -0.22% return per unit of risk over the last 3 months. Gilead Sciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gilead Sciences' Risk Adjusted Performance of (0.13), standard deviation of 1.62, and Market Risk Adjusted Performance of 5.03 to validate the risk estimate we provide.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Common Stock Total Equity is forecasted to decline to about 892.4 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.78, whereas Price To Sales Ratio is forecasted to decline to 3.54. Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of January 1992 | 200 Day MA 76.7513 | 50 Day MA 72.5936 | Beta 0.203 |
Gilead |
Sharpe Ratio = -0.2157
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GILD |
Estimated Market Risk
| 1.08 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gilead Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding Gilead Sciences to a well-diversified portfolio.
Price Book 3.7175 | Enterprise Value Ebitda 9.7756 | Price Sales 3.1303 | Shares Float 1.2 B | Dividend Share 3 |
Gilead Sciences Stock Price History Chart
There are several ways to analyze Gilead Stock price data. The simplest method is using a basic Gilead candlestick price chart, which shows Gilead Sciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 25, 2024 | 79.42 |
| Lowest Price | April 17, 2024 | 66.93 |
Gilead Sciences April 19, 2024 Stock Price Synopsis
Various analyses of Gilead Sciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gilead Stock. It can be used to describe the percentage change in the price of Gilead Sciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gilead Stock.| Gilead Sciences Price Rate Of Daily Change | 0.99 | |
| Gilead Sciences Price Daily Balance Of Power | (0.58) | |
| Gilead Sciences Price Action Indicator | (0.47) |
Gilead Sciences April 19, 2024 Stock Price Analysis
Gilead Stock Price History Data
The price series of Gilead Sciences for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 19.47 with a coefficient of variation of 5.96. Under current investment horizon, the daily prices are spread out with arithmetic mean of 74.01. The median price for the last 90 days is 72.92. The company completed 2:1 stock split on 28th of January 2013. Gilead Sciences completed dividends distribution on 2024-03-14.| Open | High | Low | Close | Volume | ||
04/19/2024 | 67.35 | 67.54 | 66.89 | 66.93 | ||
| 04/17/2024 | 67.35 | 67.54 | 66.89 | 66.93 | 5,277,168 | |
| 04/16/2024 | 67.80 | 67.89 | 67.19 | 67.31 | 4,974,962 | |
| 04/15/2024 | 68.34 | 68.46 | 67.70 | 67.75 | 7,709,301 | |
| 04/12/2024 | 68.52 | 68.62 | 67.62 | 68.07 | 5,691,400 | |
| 04/11/2024 | 68.46 | 69.03 | 68.31 | 68.65 | 6,064,395 | |
| 04/10/2024 | 69.76 | 69.76 | 68.07 | 68.12 | 7,953,074 | |
| 04/09/2024 | 69.16 | 69.95 | 69.11 | 69.94 | 5,915,279 | |
| 04/08/2024 | 69.14 | 69.55 | 69.05 | 69.42 | 4,580,153 | |
| 04/05/2024 | 69.42 | 70.01 | 68.54 | 69.58 | 6,494,726 | |
| 04/04/2024 | 71.24 | 71.39 | 69.40 | 69.55 | 7,275,974 | |
| 04/03/2024 | 72.00 | 72.17 | 70.70 | 70.89 | 5,139,568 | |
| 04/02/2024 | 72.82 | 72.85 | 71.90 | 72.09 | 5,796,009 | |
| 04/01/2024 | 72.91 | 73.10 | 72.38 | 72.88 | 3,646,124 | |
| 03/28/2024 | 73.25 | 73.87 | 73.20 | 73.25 | 8,242,895 | |
| 03/27/2024 | 72.92 | 73.06 | 72.55 | 73.01 | 7,734,770 | |
| 03/26/2024 | 72.39 | 72.66 | 72.11 | 72.41 | 5,214,118 | |
| 03/25/2024 | 72.50 | 72.84 | 72.20 | 72.58 | 5,543,744 | |
| 03/22/2024 | 73.10 | 73.23 | 72.56 | 72.61 | 7,665,569 | |
| 03/21/2024 | 73.90 | 74.28 | 73.03 | 73.09 | 5,810,324 | |
| 03/20/2024 | 73.27 | 73.98 | 72.80 | 73.98 | 7,060,619 | |
| 03/19/2024 | 73.34 | 73.77 | 73.19 | 73.41 | 7,618,226 | |
| 03/18/2024 | 73.75 | 74.17 | 73.21 | 73.26 | 5,382,761 | |
| 03/15/2024 | 74.27 | 74.66 | 73.29 | 73.69 | 13,917,015 | |
| 03/14/2024 | 74.72 | 75.02 | 73.82 | 74.21 | 7,360,492 | |
| 03/13/2024 | 75.49 | 76.18 | 74.96 | 75.17 | 6,003,000 | |
| 03/12/2024 | 75.25 | 75.34 | 74.25 | 74.32 | 7,056,300 | |
| 03/11/2024 | 74.88 | 76.21 | 74.56 | 74.56 | 7,394,900 | |
| 03/08/2024 | 73.96 | 75.44 | 73.66 | 74.36 | 9,518,300 | |
| 03/07/2024 | 72.97 | 74.08 | 72.68 | 72.91 | 9,902,800 | |
| 03/06/2024 | 72.88 | 73.32 | 71.89 | 71.89 | 6,170,300 | |
| 03/05/2024 | 72.40 | 73.01 | 72.10 | 72.25 | 6,280,400 | |
| 03/04/2024 | 72.39 | 72.60 | 71.52 | 71.52 | 5,749,900 | |
| 03/01/2024 | 72.28 | 72.66 | 71.58 | 71.58 | 5,400,900 | |
| 02/29/2024 | 72.72 | 72.91 | 71.37 | 71.37 | 8,583,200 | |
| 02/28/2024 | 73.18 | 73.25 | 71.96 | 71.96 | 4,245,600 | |
| 02/27/2024 | 72.85 | 73.14 | 72.28 | 72.28 | 6,090,400 | |
| 02/26/2024 | 73.50 | 73.89 | 72.21 | 72.21 | 5,177,900 | |
| 02/23/2024 | 73.25 | 74.24 | 72.80 | 72.80 | 5,573,500 | |
| 02/22/2024 | 72.26 | 72.89 | 71.83 | 72.04 | 7,323,600 | |
| 02/21/2024 | 72.51 | 73.29 | 72.46 | 72.46 | 6,233,600 | |
| 02/20/2024 | 71.59 | 72.73 | 71.31 | 71.31 | 7,874,200 | |
| 02/16/2024 | 73.00 | 73.09 | 70.85 | 70.85 | 12,822,500 | |
| 02/15/2024 | 73.04 | 73.57 | 72.63 | 72.63 | 5,482,900 | |
| 02/14/2024 | 73.11 | 73.83 | 72.30 | 72.30 | 7,487,700 | |
| 02/13/2024 | 74.69 | 74.77 | 72.78 | 72.78 | 8,560,100 | |
| 02/12/2024 | 73.41 | 75.14 | 73.11 | 73.70 | 7,605,800 | |
| 02/09/2024 | 73.82 | 74.12 | 72.81 | 72.92 | 10,718,300 | |
| 02/08/2024 | 74.40 | 74.59 | 73.03 | 73.05 | 8,815,200 | |
| 02/07/2024 | 76.21 | 76.45 | 73.67 | 73.67 | 12,449,800 | |
| 02/06/2024 | 76.87 | 77.87 | 76.71 | 76.93 | 8,121,200 | |
| 02/05/2024 | 76.65 | 77.05 | 75.93 | 75.93 | 6,690,400 | |
| 02/02/2024 | 77.61 | 77.99 | 76.18 | 76.18 | 7,588,800 | |
| 02/01/2024 | 78.00 | 78.58 | 77.37 | 77.37 | 7,698,000 | |
| 01/31/2024 | 78.79 | 79.03 | 77.47 | 77.47 | 7,637,300 | |
| 01/30/2024 | 78.80 | 78.90 | 77.82 | 77.82 | 8,102,400 | |
| 01/29/2024 | 79.65 | 80.01 | 78.27 | 78.27 | 6,586,000 | |
| 01/26/2024 | 80.23 | 80.51 | 78.71 | 78.71 | 5,481,400 | |
| 01/25/2024 | 80.08 | 81.06 | 79.42 | 79.42 | 8,337,400 | |
| 01/24/2024 | 79.56 | 79.90 | 78.48 | 78.72 | 7,563,000 | |
| 01/23/2024 | 78.54 | 79.88 | 78.39 | 78.67 | 7,837,600 |
About Gilead Sciences Stock history
Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.3 B | 1.5 B | |
| Net Income Applicable To Common Shares | 5.3 B | 4.9 B |
Gilead Sciences Quarterly Net Working Capital |
|
Gilead Sciences Stock Technical Analysis
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Gilead Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | 5.02 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.